AlzChem Group AG (ACT.DE)
EUR 57.6
(-0.69%)
EUR 57.6
(-0.69%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 76.7 Million EUR | 20.91% |
| 2022 | 68.05 Million EUR | 3.09% |
| 2021 | 61.88 Million EUR | 15.87% |
| 2020 | 51.38 Million EUR | 7.47% |
| 2019 | 45.72 Million EUR | -9.42% |
| 2018 | 47.93 Million EUR | 20.35% |
| 2017 | 44.1 Million EUR | 162880.66% |
| 2016 | 35.99 Million EUR | 8.08% |
| 2015 | -30.86 Thousand EUR | -214.12% |
| 2014 | -9824.83 EUR | -121.88% |
| 2013 | 33.88 Million EUR | -18.17% |
| 2012 | -3747.22 EUR | 26.81% |
| 2011 | -5120.01 EUR | 59.22% |
| 2010 | -12.55 Thousand EUR | -136.54% |
| 2009 | -5308.38 EUR | -3.42% |
| 2008 | -5132.71 EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 25.2 Million EUR | 2.4% |
| 2024 Q2 | 49.08 Million EUR | 2.95% |
| 2023 FY | - EUR | 20.91% |
| 2023 Q2 | 17.97 Million EUR | -5.21% |
| 2023 Q4 | 42.17 Million EUR | 108.84% |
| 2023 Q1 | 18.96 Million EUR | 12.95% |
| 2023 Q3 | 20.19 Million EUR | 12.33% |
| 2022 Q4 | 16.79 Million EUR | 14.9% |
| 2022 FY | - EUR | 3.09% |
| 2022 Q1 | 18.25 Million EUR | 49.1% |
| 2022 Q2 | 20.2 Million EUR | 10.68% |
| 2022 Q3 | 14.61 Million EUR | -27.66% |
| 2021 Q3 | 13.97 Million EUR | -27.34% |
| 2021 FY | - EUR | 15.87% |
| 2021 Q4 | 12.24 Million EUR | -12.42% |
| 2021 Q2 | 19.23 Million EUR | 11.62% |
| 2021 Q1 | 17.23 Million EUR | 36.01% |
| 2020 FY | - EUR | 7.47% |
| 2020 Q2 | 16.81 Million EUR | 29.94% |
| 2020 Q1 | 12.94 Million EUR | 48.42% |
| 2020 Q3 | 12.1 Million EUR | -28.02% |
| 2020 Q4 | 12.67 Million EUR | 4.69% |
| 2019 Q2 | 14.73 Million EUR | 10.97% |
| 2019 FY | - EUR | -9.42% |
| 2019 Q1 | 13.27 Million EUR | 67.14% |
| 2019 Q3 | 13.61 Million EUR | -7.58% |
| 2019 Q4 | 8.71 Million EUR | -35.96% |
| 2018 FY | - EUR | 20.35% |
| 2018 Q4 | 7.94 Million EUR | -24.74% |
| 2018 Q3 | 10.55 Million EUR | -33.93% |
| 2018 Q2 | 15.97 Million EUR | 5.45% |
| 2018 Q1 | 15.15 Million EUR | 98.27% |
| 2017 FY | - EUR | 162880.66% |
| 2017 Q1 | 13.42 Million EUR | 91.55% |
| 2017 Q2 | -10.05 Million EUR | -174.9% |
| 2017 Q3 | 10.44 Million EUR | 203.88% |
| 2017 Q4 | 7.64 Million EUR | -26.82% |
| 2016 FY | - EUR | 8.08% |
| 2016 Q3 | 11.53 Million EUR | 0.0% |
| 2016 Q4 | 7 Million EUR | -39.26% |
| 2015 FY | - EUR | -214.12% |
| 2015 Q4 | 3.68 Million EUR | 0.0% |
| 2014 FY | - EUR | -121.88% |
| 2013 FY | - EUR | -18.17% |
| 2012 FY | - EUR | 26.81% |
| 2011 FY | - EUR | 59.22% |
| 2010 FY | - EUR | -136.54% |
| 2009 FY | - EUR | -3.42% |
| 2008 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Covestro AG | 1.07 Billion EUR | 92.831% |
| L'Air Liquide S.A. | 7.28 Billion EUR | 98.947% |
| Brenntag SE | 1.49 Billion EUR | 94.862% |
| Evonik Industries AG | 1.73 Billion EUR | 95.577% |
| Fuchs Petrolub SE | 497 Million EUR | 84.567% |
| Fuchs Petrolub SE | 497 Million EUR | 84.567% |
| LANXESS Aktiengesellschaft | -143 Million EUR | 153.638% |
| Masterflex SE | 17.66 Million EUR | -334.307% |
| Nabaltec AG | 31.97 Million EUR | -139.892% |
| Symrise AG | 841.48 Million EUR | 90.885% |
| Uzin Utz AG | 53.47 Million EUR | -43.437% |
| VERBIO Vereinigte BioEnergie AG | 122.92 Million EUR | 37.601% |
| Wacker Chemie AG | 884 Million EUR | 91.323% |